Maj-Lis Talman

Medicine & Life Sciences

1. Adipocytes 16%
2. Blood Platelets 8%
3. Blood Vessels 8%
4. Breast 66%
5. Breast Neoplasms 100%
6. Burns 8%
7. Carcinoma, Intraductal, Noninfiltrating 12%
8. Cell Lineage 8%
9. Cell- and Tissue-Based Therapy 9%
10. Data Systems 10%
11. Differentiation Antigens 11%
12. Drug Therapy 8%
13. Estrogen Receptors 15%
14. Extracellular Fluid 9%
15. Fats 14%
16. Fibroadenoma 11%
17. Fluorescence In Situ Hybridization 8%
18. Genomics 8%
19. Graft Survival 10%
20. Gynecomastia 11%
21. Hormones 11%
22. Immunohistochemistry 10%
23. Insulin-Like Growth Factor I 8%
24. Keratin-5 12%
25. Margins of Excision 9%
26. Mesenchymal Stem Cells 15%
27. Needles 9%
28. Neoplasms 26%
29. Neuroendocrine Carcinoma 22%
30. Pathologists 14%
31. Pathology 14%
32. Phosphoglycerate Dehydrogenase 14%
33. Phyllodes Tumor 24%
34. Population 8%
35. Progesterone Receptors 8%
36. Proteins 8%
37. Proteomics 12%
38. Recurrence 9%
39. Seeds 17%
40. Segmental Mastectomy 15%
41. Sentinel Lymph Node Biopsy 21%
42. Staining and Labeling 8%
43. Stem Cells 21%
44. Swine 13%
45. Tissue Array Analysis 12%
46. Transplants 12%
47. Triple Negative Breast Neoplasms 14%
48. Tumor Biomarkers 8%
49. Tumor-Infiltrating Lymphocytes 10%
50. Workload 8%